CONTENIDO

Destacados

HIVACAT

Inmunidad Celular y Genética del huésped

Inmunidad Celular y Genética del huésped

Publicaciones

  • Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals

    Ester Ballanaa, 1, Alba Ruiz-de Andresa, 1, Beatriz Mothea, b, Eva Ramirez de Arellanoc, Francisco Aguilarc, Roger Badiaa, Eulalia Graua, Bonaventura Cloteta, Margarita del Valc, d, Christian Brandera, e, José A. Estéa

    a IrsiCaixa-HIVACAT, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain b Lluita Contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain c Unidad de Inmunología Viral, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain d Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain e Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

     

    1 Both authors contributed equally to this work

    Immunobiology. 2012 Sep;217(9):889-94. doi: 10.1016/j.imbio.2011.12.012. Epub 2012 Jan 8

  • Uncommon Pathways of Immune Escape Attenuate HIV-1 Integrase Replication Capacity

    Mark A. Brockmana,b, Denis R. Choperaa, Alex Olverac, Chanson J. Brummeb,d, Jennifer Selae, Tristan J. Marklea, Eric Martina, Jonathan M. Carlsonf, Anh Q. Lea, Rachel McGovernb, Peter K. Cheungb, Anthony D. Kelleherg, Heiko Jessenh, Martin Markowitzi, Eric Rosenbergj, Nicole Frahmk, Jorge Sanchezl, Simon Mallalm, Mina Johnm, P. Richard Harriganb, David Heckermanf, Christian Branderc,n, Bruce D. Walkere and Zabrina L. Brumme a,b


    aSimon Fraser University, Burnaby, Canada bBritish Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada cAIDS Research Institute irsiCaixa, Badalona, Spain dUniversity of British Columbia, Vancouver, Canada eRagon Institute of MGH, MIT, and Harvard, Boston, Massachusetts, USA  fMicrosoft Research, Los Angeles, California, USA gKirby Institute, University of New South Wales, Sydney, Australia hJessen Praxis, Berlin, Germany iAaron Diamond AIDS Research Center, New York, New York, USA  jMassachusetts General Hospital, Boston, Massachusetts, USA kFred Hutchinson Cancer Research Center, Seattle, Washington, USA lAsociación Civil IMPACTA Salud y Educacion, Lima, Peru mMurdoch University, Perth, Australia nInstitució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

    J. Virol. June 2012 vol. 86 no. 12 6913-6923

  • HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32

    Ballana E, Riveira-Munoz E, Pou C, Bach V, Parera M, Noguera M, Santos JR, Badia R, Casadellà M, Clotet B, Paredes R, Martínez MA, Brander C, Esté JA.

    IrsiCaixa and AIDS Unit, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

    Immunobiology(2012). DOI:10.1016/j.imbio.2012.06.012.

  • Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection

    Matthew R. Henn1, Christian L. Boutwell2#, Patrick Charlebois1#, Niall J. Lennon1, Karen A. Power2, Alexander R. Macalalad1, Aaron M. Berlin1, Christine M. Malboeuf1, Elizabeth M. Ryan1, Sante Gnerre1, Michael C. Zody1, Rachel L. Erlich1, Lisa M. Green1, Andrew Berical2, Yaoyu Wang2, Monica Casali1, Hendrik Streeck2, Allyson K. Bloom2, Tim Dudek2, Damien Tully2, Ruchi Newman1, Karen L. Axten2, Adrianne D. Gladden2, Laura Battis2, Michael Kemper2, Qiandong Zeng1, Terrance P. Shea1, Sharvari Gujja1, Carmen Zedlack3, Olivier Gasser4, Christian Brander5,6, Christoph Hess4, Huldrych F. Günthard7, Zabrina L. Brumme2, Chanson J. Brumme2, Suzane Bazner8, Jenna Rychert8, Jake P. Tinsley9, Ken H. Mayer9, Eric Rosenberg8, Florencia Pereyra2, Joshua Z. Levin1, Sarah K. Young1, Heiko Jessen3, Marcus Altfeld2, Bruce W. Birren1, Bruce D. Walker2,10, Todd M. Allen2*

     

    1 Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America, 2 Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, United States of America, 3 HIV Clinic Praxis. Jessen, Berlin, Germany, 4 Immunobiology Lab, Department of Biomedicine, University Hospital Basel, Basel, Switzerland, 5 Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain, 6 Irsicaixa AIDS Research Institute-HIVACAT, Hospital University Germans Trias I Pujol, Badalona, Spain, 7 Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland, 8 Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America, 9 The Fenway Institute, Fenway Health, Boston, Massachusetts, United States of America, 10 Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America

     

    # These authors contributed equally to this work

    PLoS Pathog. 2012 Mar;8(3):e1002529. Epub 2012 Mar 8

  • Differential prevalence of the HLA-C -35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals

    Ester Ballanaa, 1, Alba Ruiz-de Andresa, 1, Beatriz Mothea, b, Eva Ramirez de Arellanoc, Francisco Aguilarc, Roger Badiaa, Eulalia Graua, Bonaventura Cloteta, Margarita del Valc, d, Christian Brandera, e, José A. Estéa
    a IrsiCaixa-HIVACAT, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain b Lluita Contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain c Unidad de Inmunología Viral, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain d Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain e Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

     

    1 Both authors contributed equally to this work

    Immunobiology. 2012 Jan 8